CCR7 Mediated Mimetic Dendritic Cell Vaccine Homing in Lymph Node for Head and Neck Squamous Cell Carcinoma Therapy

The reserved tumor antigens and endogenous danger signals in the hybrid nanovaccine activated antigen presenting cells elicited a robust T-cell response, and displayed good therapeutic efficacy in a mouse model of head and neck squamous cell carcinoma.